Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer

for
Cancer
Location: Irvine CA
Sponsor: University of California, Irvine

Sex: Male

Age: 18 - 39

Code: NCT06338475

Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Breast Cancer,
Location: Boston MA, New York NY, Tampa FL, Indianapolis IN,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06625775

Phase 1, Recruiting

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

for
Solid Tumors
Location: Philadelphia PA, Gainesville FL, Houston TX
Sponsor: Shionogi

Sex: All

Age: 18+

Code: NCT05101070

Phase 1, Phase 2, Recruiting

Umbrella Study for Single Patient Treatments in Oncology

for
Advanced Cancer, Rare Diseases
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06285500

Recruiting

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Philadelphia PA, Kissimmee FL, Gainesville FL,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06352359

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Prehab for Lung and Esophageal Cancer

for
Neoplasm of Lung, Neoplasms, Exercise, Surgery
Location: Halifax
Sponsor: Nova Scotia Health Authority

Sex: All

Age: 18+

Code: NCT06354959

Recruiting

The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction

for
Breast Neoplasms, Neoplasms by Site, Neoplasms, Breast Diseases,
Location: Surrey, Vancouver
Sponsor: University of British Columbia

Sex: Female

Age: 21+

Code: NCT01427400

Recruiting

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

for
Lung Cancer, Bilateral Cancer, Lung Transplant
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70+

Code: NCT05671887

Recruiting

A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation

for
Advanced Solid Tumor
Location: Houston TX
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.

Sex: All

Age: 18+

Code: NCT05119933

Phase 1, Phase 2, Recruiting

A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer

for
Metastatic Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06693687

Recruiting

Avera Cancer Sequencing and Analytics Protocol (ASAP)

for
Cancer, Cancer Diagnosis, Early Detection of Cancer,
Location: Marshall MN, Sioux Falls SD, Yankton SD, Mitchell SD,
Sponsor: Avera McKennan Hospital & University Health Center

Sex: All

Age: 18+

Code: NCT05142033

Recruiting

Writing Intervention With Adolescents and Young Adults With Cancer

for
Cancer Patients, Communication Research
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 15 - 25

Code: NCT05975333

Recruiting

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

for
Advanced Cancer, Metastatic Cancer
Location: Durham NC, Miami FL
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06174987

Phase 3, Recruiting

Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use

for
Systemic Inflammation, Immune Dysregulation, Injection Drug Use,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 64

Code: NCT06829238

Recruiting

Anti-GD2 ADC M3554 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, Houston TX
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT06641908

Phase 1, Recruiting

Myeloproliferative Neoplasms (MPNs) Patient Registry

for
Primary Myelofibrosis, Polycythemia Vera,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 0+

Code: NCT02760238

Recruiting

Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

for
Metastatic Malignant Neoplasm in the Brain,
Location: Philadelphia PA
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT03184038

Recruiting

AIMS Cancer Outcomes Study

for
Neoplasms, Neoplasm Malignant, Advanced Cancer,
Location: Seattle WA
Sponsor: Advanced Integrative Medical Science Institute

Sex: All

Age: 0+

Code: NCT04495790

Recruiting

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

for
Malignant Neoplasm
Location: Albuquerque NM
Sponsor: New Mexico Cancer Research Alliance

Sex: All

Age: 18+

Code: NCT06207864

Recruiting

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

for
Malignant Neoplasms, Hereditary Neoplastic Syndromes,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2+

Code: NCT00026884

Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial